Therapeutic Drug Monitoring Market Generated Opportunities, Future Scope 2022-2028 | Roche Diagnostics, Thermo Fisher Scientific, Bio Rad Laboratories

Therapeutic drug monitoring measures the amount of a medication in the patient’s blood to ensure that they are taking the right dosage. Although most medicines can be safely dosed without this testing, some can only be used in the most extreme situations. This is where drug monitoring comes in. With the help of a medical lab, drug providers can measure the exact concentration of a medicine in the patient’s blood and adjust their dosage accordingly. In the case of chronic conditions, such as kidney, liver, or thyroid disease, the use of therapeutic drug monitoring is essential to monitor the patient’s progress and safety.

Request Here For PDF Brochure With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/1241

The therapeutic drug monitoring process involves measuring the concentration of a drug in a patient’s blood. This is important to maintain a constant level of medication in the body. Because of the fact that each individual’s metabolism and absorption rates vary, it is impossible to achieve the same level of medication in the blood with standard doses. This makes it vital to monitor the concentration of a drug in the patient’s blood and make adjustments for individual differences.

Global Therapeutic Drug Monitoring Market: Drivers

Increasing number of organ transplant is expected to propel growth of the global therapeutic drug monitoring market over the forecast period. For instance, according to Waters Corporation Blog, China witnessed 35% y-o-y increase in organ transplant in the first 4 months of 2017.

Moreover, increasing cases of antimicrobial resistance is also expected to propel growth of the global therapeutic drug monitoring market over the forecast period. For instance, according to WHO Factsheet 2017, around 480,000 multi-drug resistance TB cases were reported.

Market Trends

North America is expected to witness significant growth in the global therapeutic drug monitoring market, owing to high consumption of anti-psychotic drugs in the region. For instance, 1 in 7 people in the U.S consume anti-psychotic drugs, according to 2013 survey by Medical Expenditure Panel published in Scientific American. Consumption of anti-psychotic drugs requires therapeutic drug monitoring.

Major players operating in the global therapeutic drug monitoring market are focused on adopting merger and acquisition strategies to expand their product portfolio. For instance, in 2016, Danaher Corporation acquired Cepheid at US$ 4 billion to strengthen company’s diagnostic portfolio.

Global Therapeutic Drug Monitoring Market: Restraints

Difficulty in reimbursement and high cost associated with therapeutic drug monitoring is expected to hinder growth of the global therapeutic drug monitoring market.

Get Sample Report With Latest Covid19 Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/1241

Global Therapeutic Drug Monitoring Market: Competitive Landscape

Major players operating in the global therapeutic drug monitoring market include, Abbott Diagnostics, Beckmann Coulter, Bio Rad Laboratories, Roche Diagnostics, Siemens Healthcare Diagnostics, and Thermo Fisher Scientific.

Global Therapeutic Drug Monitoring Market: Segmentation

On the basis of product, the global therapeutic drug monitoring market is segmented into:

• Equipment
• Consumables

On the basis of technology, the global therapeutic drug monitoring market is segmented into:

• Enzyme Immunoassay
• HPLC LC/MS
• GC/MS
• Fluorescence Polarization Immunoassay
• Mass Spectrometry

On the basis of end user, the global therapeutic drug monitoring market is segmented into:

• Hospitals
• Pathological Labs
• Pharmaceutical and Biotechnology Industries
• Research and Academic Institutes

Buy This Complete Business Report With Flat USD 2000 Off@ https://www.coherentmarketinsights.com/promo/buynow/1241

Reasons to Purchase This Report

• Current and future of Therapeutic Drug Monitoring Market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players

Table of Content

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Therapeutic Drug Monitoring Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Therapeutic Drug Monitoring Industry Impact

Chapter 2 Global Therapeutic Drug Monitoring Competition by Types, Applications, and Top Regions and Countries
2.1 Global Therapeutic Drug Monitoring (Volume and Value) by Type
2.3 Global Therapeutic Drug Monitoring (Volume and Value) by Regions

Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 Global Therapeutic Drug Monitoring Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Therapeutic Drug Monitoring Market Analysis
Chapter 6 East Asia Therapeutic Drug Monitoring Market Analysis
Chapter 7 Europe Therapeutic Drug Monitoring Market Analysis
Chapter 8 South Asia Therapeutic Drug Monitoring Market Analysis
Chapter 9 Southeast Asia Therapeutic Drug Monitoring Market Analysis
Chapter 10 Middle East Therapeutic Drug Monitoring Market Analysis
Chapter 11 Africa Therapeutic Drug Monitoring Market Analysis
Chapter 12 Oceania Therapeutic Drug Monitoring Market Analysis
Chapter 13 South America Therapeutic Drug Monitoring Market Analysis
Chapter 14 Company Profiles and Key Figures in Therapeutic Drug Monitoring Business
Chapter 15 Global Therapeutic Drug Monitoring Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology